After Musk’s X, Yaccarino Shifts to Run GLP-1 Tech Upstart

Linda Yaccarino

Photographer: Bridget Bennett/Bloomberg

Linda Yaccarino, who recently left Elon Musk’s X social media site, is taking the helm at eMed, a telehealth company that offers access to weight-loss drugs.

The digital health upstart sold Covid tests with results it confirmed virtually during the pandemic, then pivoted to offering weight-loss drugs more recently. The company announcedBloomberg Terminal Yaccarino’s appointment as chief executive officer on Tuesday.